Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


An Open-Label Clinical Trial of Simultaneous Administration of Oral Aspirin and Ketamine as Adjunct to Oral Antidepressant Therapy in Treatment-Resistant Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05615948

Organisation Name: Maimonides Medical Center

Overal Status: Recruiting

Start Date: December 6, 2022

Last Update: December 14, 2022

Lead Sponsor: Maimonides Medical Center

Brief Summary: The purpose of this study is to assess the effects of simultaneous administration of oral aspirin and oral ketamine as a therapeutic for those with Treatment Resistant Depression.

Conditions:
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Analgesia
  • Ketamine
  • Peripheral Nervous System Agents
  • Central Nervous System Depressants
  • Neurotransmitter Agents
  • Anti-Inflammatory Agents
  • Physiological Effects of Drugs
  • Sensory System Agents
  • Analgesics, Non-Narcotic
  • Anti-Inflammatory Agents, Non-Steroidal
  • Depressive Symptoms


Total execution time in seconds: 0.21348595619202